Talphera (TLPH) Non-Current Deffered Revenue (2010 - 2022)
Talphera (TLPH) recorded quarterly Non-Current Deffered Revenue of $1.0 million in Q4 2022, down 2.63% quarter-over-quarter from $1.1 million in Q3 2022, and down 9.99% on a YoY basis from $1.2 million in Q4 2021.
Talphera (TLPH) Non-Current Deffered Revenue (2010 - 2022) Analysis & Trends
Talphera's Non-Current Deffered Revenue history runs 13 years deep, the most recent figure standing at $1.0 million for Q4 2022.
- In Q4 2022, Non-Current Deffered Revenue fell 9.99% year-over-year to $1.0 million; the TTM figure through Dec 2022 stood at $1.0 million (down 9.99% YoY), while the FY2022 annual figure was $1.0 million, down 9.99% from the prior year.
- Non-Current Deffered Revenue was $1.0 million for Q4 2022 at Talphera, down from $1.1 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $3.1 million in Q4 2018 to a low of $442000.0 in Q3 2018.
- Historically, Non-Current Deffered Revenue has averaged $1.7 million across 5 years, with a median of $1.2 million in 2021.
- The sharpest annual moves came in 2018 and 2019: Non-Current Deffered Revenue sank 87.56% in 2018, then surged 558.82% in 2019.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $3.1 million in 2018, then fell by 10.01% to $2.8 million in 2019, then fell by 2.79% to $2.8 million in 2020, then sank by 58.21% to $1.2 million in 2021, then fell by 9.99% to $1.0 million in 2022.
- The last three Non-Current Deffered Revenue figures came in at $1.0 million (Q4 2022), $1.1 million (Q3 2022), and $1.1 million (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 1.24 Mn |
| Mar 31, 2020 | 2.75 Mn |
| Dec 31, 2019 | 2.83 Mn |
| Sep 30, 2019 | 2.91 Mn |
| Jun 30, 2019 | 2.99 Mn |
| Mar 31, 2019 | 3.07 Mn |
| Dec 31, 2018 | 3.15 Mn |
| Sep 30, 2018 | 442,000.00 |
| Jun 30, 2018 | 468,000.00 |
| Mar 31, 2018 | 494,000.00 |
| Dec 31, 2017 | 3.46 Mn |
| Sep 30, 2017 | 3.55 Mn |
| Jun 30, 2017 | 3.64 Mn |
| Mar 31, 2017 | 3.73 Mn |
| Dec 31, 2016 | 3.82 Mn |